CARDINAL HEALTH INC

Wholesale-Drugs, Proprietaries & Druggists' Sundries·DUBLIN, OH·FY end 06/30·CIK 721371

CEO Pay Ratio

261:1

Jason M. Hollar

CEO Total Comp

$19.0M

Jason M. Hollar

Median Employee

$72,657

Revenue

$222.6B

FY 2025

Net Income

$1.6B

FY 2025

Free Cash Flow

$1.9B

FY 2025

Net Margin

0.7%

Insider Net (180d)

-$2.1M

0 buys / 4 sales

CEO Pay Accountability

CEO comp as % of net income

1.22%

For every $1,000 of profit, $12.16 flows to the CEO.

CEO comp as % of buybacks

2.48%

CEO comp equals 24.8‰ of cash returned to shareholders via buybacks.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$222.6B	$54.9B	$205.0B	$181.4B	$162.5B
Gross Profit	$8.2B	$1.9B	$6.9B	$6.5B	$6.8B
Operating Income	$2.3B	$369.0M	$727.0M	-$596.0M	$472.0M
Net Income	$1.6B	$261.0M	$261.0M	-$933.0M	$611.0M
Operating CF	$2.4B	$3.8B	$2.8B	$3.1B	$2.4B
Capex	$547.0M	$511.0M	$481.0M	$387.0M	$400.0M
Free Cash Flow	$1.9B	$3.3B	$2.4B	$2.7B	$2.0B
Buybacks	$765.0M	$750.0M	$2.0B	$1.0B	$200.0M
Dividends	$494.0M	$499.0M	$525.0M	$559.0M	$573.0M

Gross Margin	3.7%	3.5%	3.4%	3.6%	4.2%
Operating Margin	1.0%	0.7%	0.4%	-0.3%	0.3%
Net Margin	0.7%	0.5%	0.1%	-0.5%	0.4%
FCF Margin	0.8%	5.9%	1.2%	1.5%	1.2%
R&D / Revenue	—	—	—	—	—	—
Effective Tax	25.3%	23.4%	58.9%	-21.2%	—
Debt / Equity	—	—	—	—	—	—
Buybacks / FCF	41.4%	23.1%	84.8%	36.6%	9.9%

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Jason M. HollarChief Executive Officer	$1.5M	$13.4M	—	$3.6M	$500.7K	$19.0M
Aaron E. AltChief Financial Officer	$871.2K	$4.0M	—	$1.3M	$57.8K	$6.2M
Deborah L. WeitzmanChief Executive Officer, Pharmaceutical and Specialty Solutions Segment	$741.9K	$3.8M	—	$964.5K	$30.2K	$5.5M
Jessica L. MayerChief Legal and Compliance Officer	$716.9K	$3.2M	—	$975.0K	$30.4K	$4.9M
Stephen M. MasonChief Executive Officer, Global Medical Products and Distribution Segment	$741.9K	$3.4M	—	$593.5K	$51.6K	$4.7M